Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Amneal Pharmaceuticals A | AMRX | 7. jan 2025 | 7.87 | +1.29 |
Ampco-Pittsburgh | AP | 7. jan 2025 | 2.29 | -1.72 |
Amphastar Pharmaceuticals | AMPH | 7. jan 2025 | 35.25 | -0.51 |
Amphenol | APH | 7. jan 2025 | 71.46 | +0.46 |
Amplify Energy | AMPY | 7. jan 2025 | 6.26 | +1.95 |
Amplify Online Retail ETF | IBUY | 7. jan 2025 | 65.80 | -1.03 |
Amplify Transformational Data Sharing ETF | BLOK | 7. jan 2025 | 45.74 | -4.71 |
Amplitech Group | AMPG | 7. jan 2025 | 3.63 | -8.79 |
Amplitude A | AMPL | 7. jan 2025 | 10.60 | -7.91 |
Amprius Technologies | AMPX | 7. jan 2025 | 3.54 | -7.81 |
AMREP | AXR | 7. jan 2025 | 29.62 | -3.20 |
AMTD Digital ADR | HKD | 7. jan 2025 | 2.84 | -2.74 |
AMTD Idea Group ADR | AMTD | 7. jan 2025 | 1.14 | -4.20 |
Amtech Systems | ASYS | 7. jan 2025 | 5.64 | -0.70 |
Amylyx Pharmaceuticals | AMLX | 7. jan 2025 | 3.84 | -2.04 |
AN2 Therapeutics | ANTX | 7. jan 2025 | 1.35 | -2.17 |
Analog Devices | ADI | 7. jan 2025 | 215.87 | -0.98 |
AnaptysBio | ANAB | 7. jan 2025 | 14.83 | -3.07 |
Anavex Life Sciences | AVXL | 7. jan 2025 | 13.46 | +2.67 |
Andretti Acquisition II | POLE | 7. jan 2025 | 10.03 | 0.00 |
Andretti Acquisition II Unit | POLEU | 7. jan 2025 | 10.08 | +0.30 |
Anebulo Pharmaceuticals | ANEB | 7. jan 2025 | 1.64 | +1.24 |
Angel Oak Financial Strategies | FINS | 7. jan 2025 | 12.85 | -0.46 |
Angel Oak Mortgage REIT | AOMR | 7. jan 2025 | 9.73 | -1.92 |
Anghami | ANGH | 7. jan 2025 | 0.80 | +2.56 |
Angi A | ANGI | 7. jan 2025 | 1.62 | -1.82 |
AngioDynamics | ANGO | 7. jan 2025 | 9.40 | +1.40 |
Anglogold Ashanti | AU | 7. jan 2025 | 24.45 | +3.91 |
Anheuser-Busch InBev ADR | BUD | 7. jan 2025 | 49.22 | +0.16 |
ANI Pharmaceuticals | ANIP | 7. jan 2025 | 54.38 | -0.40 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.